Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366417 · ClinicalTrials.gov registry record · Phase 4
Topical Antimicrobial Effectiveness Testing
A Phase 4 study, sponsored by C. R. Bard.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT01366417: Completed Phase 4 study, sponsored by C. R. Bard.
NCT01366417 is a Phase 4 study that has completed, run by C. R. Bard. The registered enrollment target is 25 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01366417, a Phase 4 study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
The primary objective of this study is to measure the antimicrobial effectiveness of ChloraPrep One-Step Frepp Applicator.
Primary Outcome
Antimicrobial efficacy will be measured by the change (+/-) in bacterial count on the skin 30 seconds after a single application of test material relative to the baseline bacterial count.
Interventions
- DRUG ChloraPrep One-Step
- DRUG 70% isopropyl alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
What the finished NCT01366417 record still lists
NCT01366417 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which ChloraPrep One-Step is the first listed.
NCT01366417 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01366417 about?
NCT01366417 is a clinical study titled "Topical Antimicrobial Effectiveness Testing". The primary objective of this study is to measure the antimicrobial effectiveness of ChloraPrep One-Step Frepp Applicator.
What is the current status of trial NCT01366417?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2011-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01366417?
The interventions under investigation include: ChloraPrep One-Step (DRUG), 70% isopropyl alcohol (DRUG).
Who is sponsoring clinical trial NCT01366417?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01366417's enrollment target sits among peer trials
25 1669th of 2000 higher than 302 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia